Skip to main content
Log in

Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The present study was performed to determine the prevalence of metabolic syndrome (MS) and its risk factors in obese children and adolescents. The study included 352 obese children and adolescents (body mass index [BMI] ≥ 95th percentile) aged between 2 and 19 years. The diagnosis of MS was made according to the criteria adapted from the World Health Organization (WHO) and the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines. BMI z-scores were calculated to assess the degree of obesity. The prevalence of MS and risk factors were determined. Determinants of MS were examined using regression analysis. The prevalence of MS was 41.8%. The age at onset of obesity, sedentary life-span, fasting blood levels of glucose, insulin, triglyceride, very-low-density lipoprotein (VLDL) cholesterol, and alanine aminotransferase (ALT) were higher, while levels of high-density lipoprotein (HDL) cholesterol and the number of actively spent hours were lower in cases with MS (p < 0.05). The most important determinant of MS was BMI z-score (r = 0.31, p < 0.0001). A one-point increase in BMI z-score yielded a 2-fold increase in the prevalence of MS. The prevalence of MS increased from 27.6% to 60.7% when the BMI z-score increased from 2.3 to 3.3. The risk of developing MS was 2.6-fold higher in cases with BMI z-score > 3 when compared to those with z-scores between 2 and 3. The results from this study indicate that, although the correlation between MS and the BMI z-score was weak, the BMI z-score may be an effective parameter in identifying obese children and adolescents at risk for MS. Screening the cases with BMI z-scores ≥ 2 for MS is important for establishing an early diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DM:

Diabetes mellitus

MS:

Metabolic syndrome

BMI:

Body mass index

HT:

Hypertension

DL:

Dyslipidemia

OGTT:

Oral glucose tolerance test

HI:

Hyperinsulinism

HOMA-IR:

Homeostasis model assessment of insulin resistance

CV:

Cardiovascular

TG:

Triglyceride

C:

Cholesterol

HDL:

High-density lipoprotein

LDL:

Low-density lipoprotein

VLDL:

Very-low-density lipoprotein

References

  1. Abate N (2000) Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14:154–174

    Article  PubMed  CAS  Google Scholar 

  2. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553

    Article  PubMed  CAS  Google Scholar 

  3. Alikasifoglu A, Yordam N (1999) The metabolic parameters of obese children and the role of hyperinsulinism on weight loss. Eur J Pediatr 158:269–270

    Article  PubMed  CAS  Google Scholar 

  4. Atabek ME, Pirgon O, Kurtoglu S (2006) Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract 72:315–321

    Article  PubMed  CAS  Google Scholar 

  5. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338:1650–1656

    Article  PubMed  CAS  Google Scholar 

  6. Bloomgarden ZT (2004) Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome. Diabetes Care 27:824–830

    Article  PubMed  Google Scholar 

  7. Cameron AJ, Shaw JE, Zimmet PZ (2004) The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33:351–375

    Article  PubMed  Google Scholar 

  8. Centers for Disease Control and Prevention/National Center for Health Statistics (CDC/NCHS) (2000) CDC growth charts: United States. Home page at http://www.cdc.gov/growthcharts

  9. Chen W, Srinivasan SR, Elkasabany A, Berenson GS (1999) The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study. Atherosclerosis 145:197–205

    Article  PubMed  CAS  Google Scholar 

  10. Cizmecioglu F, Ozcan A, Kalaca S, Hatun S (2002) Çocukluk çağında metabolik sendrom sıklığı ve risk faktörleri. IX National Pediatric Endocrinology Congress, Malatya, Turkey, p 307

  11. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240–1243

    Article  PubMed  CAS  Google Scholar 

  12. Cole TJ, Freeman JV, Preece MA (1995) Body mass index reference curves for the UK, 1990. Arch Dis Child 73:25–29

    Article  PubMed  CAS  Google Scholar 

  13. Conwell LS, Trost SG, Brown WJ, Batch JA (2004) Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 27:314–319

    Article  PubMed  Google Scholar 

  14. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 157:821–827

    Article  PubMed  Google Scholar 

  15. Cruz ML, Goran MI (2004) The metabolic syndrome in children and adolescents. Curr Diab Rep 4:53–62

    Article  PubMed  Google Scholar 

  16. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI (2004) The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 89:108–113

    Article  PubMed  CAS  Google Scholar 

  17. Csábi G, Török K, Jeges S, Molnár D (2000) Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 159:91–94

    Article  PubMed  Google Scholar 

  18. Daniels SR, Arnett DK, Eckel RH, Gidding SS, Hayman LL, Kumanyika S, Robinson TN, Scott BJ, St Jeor S, Williams CL (2005) Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 111:1999–2012

    Article  PubMed  Google Scholar 

  19. Freeman MS, Mansfield MW, Barrett JH, Grant PJ (2002) Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med 19:994–999

    Article  PubMed  CAS  Google Scholar 

  20. Garrow JS (1981) Treat obesity seriously: a clinical manual. Churchill Livingstone, Edinburgh, UK

    Google Scholar 

  21. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM (2004) Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 145:445–451

    Article  PubMed  Google Scholar 

  22. Goran MI, Gower BA (2001) Longitudinal study on pubertal insulin resistance. Diabetes 50:2444–2450

    Article  PubMed  CAS  Google Scholar 

  23. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, Johnson CL (1998) Distributions and trends of serum lipid levels among United States children and adolescents ages 4–19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 27:879–890

    Article  PubMed  CAS  Google Scholar 

  24. Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G (2003) Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 26:118–124

    Article  PubMed  Google Scholar 

  25. Kalkan S, Ozcan T, Darcan S, Dizdaner C (2002) Izmir ili Bornova ilcesinde 6–10.5 ya° arasinda 4548 cocugun obesite prevalansi ve risk faktorleri acisindan degerlendirilmesi. VII National Pediatric Endocrinology Congress, Trabzon, Turkey, p 161

  26. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C (2005) Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115:e500–e503

    Article  PubMed  Google Scholar 

  27. Levitt NS, Lambert EV (2002) The foetal origins of the metabolic syndrome—a South African perspective. Cardiovasc J S Afr 13:179–180

    PubMed  Google Scholar 

  28. Lusting RH, Preeyasombat C, Velasquez-Mieyer PA (2004) Childhood obesity. In: Pescovitz OH, Eugster EA (eds) Pediatric endocrinology: mechanisms, manifestations and management, Chap 43. Lippincott Williams and Wilkins, Philadelphia, Pennsylvania, pp 682–714

    Google Scholar 

  29. Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291–303

    PubMed  CAS  Google Scholar 

  30. Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13–23

    PubMed  CAS  Google Scholar 

  31. Molnár D (2004) The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents. Int J Obes Relat Metab Disord 28(Suppl 3):S70–S74

    Article  PubMed  Google Scholar 

  32. Newman WP 3rd, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS (1986) Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 314:138–144

    Article  PubMed  Google Scholar 

  33. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555

    Article  PubMed  CAS  Google Scholar 

  34. Rodríguez-Morán M, Salazar-Vázquez B, Violante R, Guerrero-Romero F (2004) Metabolic syndrome among children and adolescents aged 10–18 years. Diabetes Care 27:2516–2517

    Article  PubMed  Google Scholar 

  35. Saglam H, Erokutan I, Tarım O (2002) Bursa ili merkezinde 6–12 yas grubu okul cocuklarinda obesite prevalansi ve etkileyen faktorler. VII National Pediatric Endocrinology Congress, Trabzon, Turkey, p 93

  36. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802–810

    Article  PubMed  CAS  Google Scholar 

  37. Smith-Miller CA (2004) Is watching television making kids fat? Fighting childhood obesity with the push of a button. Am J Nurs 104:13

    PubMed  Google Scholar 

  38. Steinberger J (2003) Diagnosis of the metabolic syndrome in children. Curr Opin Lipidol 14:555–559

    Article  PubMed  CAS  Google Scholar 

  39. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–S20

    Google Scholar 

  40. Tümer N, Yalçinkaya F, Ince E, Ekim M, Köse K, Cakar N, Kara N, Ozkaya N, Ensari C, Onder S (1999) Blood pressure nomograms for children and adolescents in Turkey. Pediatr Nephrol 13:438–443

    Article  PubMed  Google Scholar 

  41. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P (2005) Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 90:10–14

    Article  PubMed  CAS  Google Scholar 

  42. Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, Mayer H, Kratzer W, Debatin KM, Heinze E (2004) Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord 28:307–313

    PubMed  CAS  Google Scholar 

  43. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374

    Article  PubMed  CAS  Google Scholar 

  44. Whincup PH, Gilg JA, Papacosta O, Seymour C, Miller GJ, Alberti KG, Cook DG (2002) Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ 324:635

    Article  PubMed  Google Scholar 

  45. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Grüters A (2004) Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity—a problem that is no longer restricted to minority groups. Eur J Endocrinol 151:199–206

    Article  PubMed  CAS  Google Scholar 

  46. Zachrisson I, Tibell C, Bang P, Ortquist E (2003) Prevalence of type 2 diabetes among known cases of diabetes aged 0–18 years in Sweden. Diabetologia 46(Suppl 2):56

    Google Scholar 

  47. Zannolli R, Rebeggiani A, Chiarelli F, Morgese G (1993) Hyperinsulinism as a marker in obese children. Am J Dis Child 147:837–841

    PubMed  CAS  Google Scholar 

  48. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S, International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes (2007) The metabolic syndrome in children and adolescents. Lancet 369:2059–2061

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasar Sen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sen, Y., Kandemir, N., Alikasifoglu, A. et al. Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. Eur J Pediatr 167, 1183–1189 (2008). https://doi.org/10.1007/s00431-007-0658-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-007-0658-x

Keywords

Navigation